← GLP-1 receptor agonists × glycemic controlTrialDiabetic medicine : a journal of the British Diabetic Association2011
Liraglutide improves treatment satisfaction in people with Type 2 diabetes compared with sitagliptin, each as an add on to metformin.
M Davies et al.PubMed ↗Publisher ↗
A later paper about NCT00700817. The trial’s primary report, PMID 20417856, speaks for it on the map; the numbers here are shown and do not vote.
What the trial testedas reported · 658 people · 2011
No range givenReported lower glycemic control, no range given
−0.88
As reported
difference −0.88, no interval
One number in the abstract
Where each one falls
Where it lands on the map
the abstract, start to end
… with liraglutide 1.8 mg (difference = -0.88; P < 0.0001) and 1.2 mg ( …
← favours treatmentfavours comparator →
could be chanceNo interval given · direction only, strength unknown
GLP-1 receptor agonistsGlycemic control
24 papers cite it
this paperpooled ittrialcites it